Stock Scorecard



Stock Summary for Natera Inc (NTRA) - $143.94 as of 3/28/2025 8:34:06 PM EST

Total Score

6 out of 30

Safety Score

51 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for NTRA

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for NTRA

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for NTRA

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for NTRA

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for NTRA (51 out of 100)

Stock Price Rating (Max of 10) 10
Historical Stock Price Rating (Max of 10) 9
Stock Price Trend (Max of 10) 9
Book Value (Max of 10) 4
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 5
Analyst Strong Buy Ratings (Max of 5) 5
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 9
Price to Earnings (Max of 10) 0
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for NTRA

Oncocyte Reports Successful 2024; Sets Stage for 2025 Catalysts 3/24/2025 8:05:00 PM
Is Invesco Biotechnology & Genome ETF ( PBE ) a Strong ETF Right Now? 3/17/2025 10:20:00 AM
How Do Investors Really Feel About Natera? - Natera ( NASDAQ:NTRA ) 3/11/2025 8:00:00 PM
Natera ( NTRA ) Reports Q4 Loss, Tops Revenue Estimates 2/27/2025 11:20:00 PM
DENTSPLY SIRONA to Post Q4 Earnings: What's in Store for the Stock? 2/24/2025 6:57:00 PM
Is Gilead Sciences ( GILD ) Outperforming Other Medical Stocks This Year? 2/20/2025 2:40:00 PM
Stanley Druckenmiller Ditches Broadcom, Ups Ante On Big Tech Including Tesla - Autodesk ( NASDAQ:ADSK ) , Adobe ( NASDAQ:ADBE ) 2/18/2025 7:17:00 AM
$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Today - Natera ( NASDAQ:NTRA ) 2/17/2025 11:00:00 PM
HSIC Gears Up for Q4 Earnings: Here's What You Need to Know 2/17/2025 3:00:00 PM
Natera ( NTRA ) Recently Broke Out Above the 20-Day Moving Average 2/17/2025 2:35:00 PM

Financial Details for NTRA

Company Overview

Ticker NTRA
Company Name Natera Inc
Country USA
Description Natera, Inc., a diagnostic company, develops and markets molecular testing services globally. The company is headquartered in San Carlos, California.
Sector Name LIFE SCIENCES
Industry Name SERVICES-MEDICAL LABORATORIES
Most Recent Quarter 12/31/2024
Next Earnings Date 6/12/2025

Stock Price History

Last Day Price 143.94
Price 4 Years Ago 93.39
Last Day Price Updated 3/28/2025 8:34:06 PM EST
Last Day Volume 1,258,163
Average Daily Volume 2,081,146
52-Week High 183.00
52-Week Low 83.13
Last Price to 52 Week Low 73.15%

Valuation Measures

Trailing PE N/A
Industry PE 210.46
Sector PE 40.10
5-Year Average PE -36.24
Free Cash Flow Ratio 327.14
Industry Free Cash Flow Ratio 8.27
Sector Free Cash Flow Ratio 47.05
Current Ratio Most Recent Quarter 4.39
Total Cash Per Share 0.44
Book Value Per Share Most Recent Quarter 9.01
Price to Book Ratio 16.94
Industry Price to Book Ratio 2.28
Sector Price to Book Ratio 21.92
Price to Sales Ratio Twelve Trailing Months 11.94
Industry Price to Sales Ratio Twelve Trailing Months 2.34
Sector Price to Sales Ratio Twelve Trailing Months 27.78
Analyst Buy Ratings 12
Analyst Strong Buy Ratings 7

Share Statistics

Total Shares Outstanding 135,186,000
Market Capitalization 19,458,672,840
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0000
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth 20.63%
Reported EPS 12 Trailing Months -1.53
Reported EPS Past Year -1.53
Reported EPS Prior Year -3.79
Net Income Twelve Trailing Months -214,685,000
Net Income Past Year -434,800,000
Net Income Prior Year -547,799,000
Quarterly Revenue Growth YOY 53.00%
5-Year Revenue Growth 34.04%
Operating Margin Twelve Trailing Months -13.60%

Balance Sheet

Total Cash Most Recent Quarter 58,980,000
Total Cash Past Year 236,882,000
Total Cash Prior Year 898,305,000
Net Cash Position Most Recent Quarter -227,569,000
Net Cash Position Past Year -46,063,000
Long Term Debt Past Year 282,945,000
Long Term Debt Prior Year 281,653,000
Total Debt Most Recent Quarter 286,549,000
Equity to Debt Ratio Past Year 0.73
Equity to Debt Ratio Most Recent Quarter 0.75
Total Stockholder Equity Past Year 765,327,000
Total Stockholder Equity Prior Year 705,744,000
Total Stockholder Equity Most Recent Quarter 878,525,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months -33,185,000
Free Cash Flow Per Share Twelve Trailing Months -0.25
Free Cash Flow Past Year -286,154,000
Free Cash Flow Prior Year -479,198,000

Options

Put/Call Ratio 12.15
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -2.30
MACD Signal -3.64
20-Day Bollinger Lower Band 140.42
20-Day Bollinger Middle Band 161.75
20-Day Bollinger Upper Band 183.08
Beta 1.80
RSI 44.31
50-Day SMA 131.69
150-Day SMA 78.18
200-Day SMA 80.75

System

Modified 3/28/2025 3:21:04 AM EST